Baiyunshan (600332.SH) has obtained the drug registration certificate for sustained-release tablets of Quetiapine Hydrochloride (35mg).

Wisdom Financial News APP news, Baiyunshan (600332.SH) announced that recently, Baiyunshan Pharmaceutical General Factory, a subsidiary of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd., received the "Drug Registration Certificate" issued by the National Medical Products Administration for the sustained-release tablets of quetiapine hydrochloride (35mg).